Loading...

GH GUARDANT HEALTH INC US FDA Inspections 8-K Filing

GRDN

GH

GUARDANT HEALTH INC

(GH)

2023 8-K

Quarterly Results Released

Leadership Change

Financial Results Announced

Quarterly Financial Update

Stock Offering Details

Financial Results Report

Investor Day Announcement

Board Appointment

Financial Statements

Financial Statements

Lease Extension

Financial Results

Debt Restructuring

Financial Results

Financial Results

Director Appointment

Earnings Reports

Appointment of Director

Amendment to Executive Seve...

FDA Approval for Shield Blo...

Earnings Reports

Compensation Agreement with...

Earnings Reports

Resignation of Director

Financial Results

FDA Review of Shield Blood ...

Earnings Reports

Resignation of COO

Financial Results Announcement

Collaboration Agreement wit...

Annual Meeting Results

Underwriting Agreement

Financial Results Announcement

Presentation at Conference

Appointment of Chief Operat...

Accounting Firm Change

Regulation FD Disclosure

Appointment of Director

Earnings Reports

Financial Results

External Links:

Guardant Health, Inc. announced that the FDA will review its Shield blood test for colorectal cancer on March 28, 2024.

AI Assistant

GUARDANT HEALTH INC

2023

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.